5901 - 5910 of 8436 Results
Title
Year
-
OPENTitle: Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical ConsiderationsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2018.00614Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2018.00614/pdfCitation Count: 33
-
RESTRICTEDTitle: A Cortical Pathogenic Theory of Parkinson’s DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 99Issue #: 6Start Page: 1116End Page: 1128Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2018.07.028Best OA location URL: http://www.cell.com/article/S0896627318306263/pdfCitation Count: 116
-
OPENTitle: Lead-DBS v2: Towards a comprehensive pipeline for deep brain stimulation imagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 184Issue #:Start Page: 293End Page: 316Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.08.068Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811918307663?via%3DihubCitation Count: 652
-
RESTRICTEDTitle: Post-stroke Movement Disorders: The Clinical, Neuroanatomic, and Demographic Portrait of 284 Published CasesJournal Name: Journal of Stroke and Cerebrovascular DiseasesPublisher: Elsevier BVVol: 27Issue #: 9Start Page: 2388End Page: 2397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jstrokecerebrovasdis.2018.04.028Best OA location URL: https://zenodo.org/records/3873438/files/Proof_from_JSCVD-D-18-00257R1.pdfCitation Count: 65
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 50
-
OPENTitle: Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD)Journal Name: Annals of Biomedical EngineeringPublisher: Springer Science and Business Media LLCVol: 47Issue #: 1Start Page: 282End Page: 296Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10439-018-02112-0Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2018/03/03/200543.full.pdfCitation Count: 27
-
OPENTitle: Antibody biomarker for de novo Parkinson disease: attempted validationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0064-2Best OA location URL: https://www.nature.com/articles/s41531-018-0064-2.pdfCitation Count: 11
-
OPENTitle: Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutationsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 15Issue #: 1Start Page: 113End Page: 130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2018.1509818Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2018.1509818?needAccess=trueCitation Count: 193
-
OPENTitle: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1286-2Best OA location URL: https://doi.org/10.1186/s12974-018-1286-2Citation Count: 81
-
OPENTitle: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 215Issue #: 9Start Page: 2247End Page: 2264Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20180484Best OA location URL: https://rupress.org/jem/article-pdf/215/9/2247/1171465/jem_20180484.pdfCitation Count: 65